NM_207346.3:c.1310C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_207346.3(TSEN54):​c.1310C>T​(p.Ala437Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 1,613,570 control chromosomes in the GnomAD database, including 372,403 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A437I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.64 ( 31161 hom., cov: 31)
Exomes 𝑓: 0.68 ( 341242 hom. )

Consequence

TSEN54
NM_207346.3 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:14

Conservation

PhyloP100: 0.442

Publications

48 publications found
Variant links:
Genes affected
TSEN54 (HGNC:27561): (tRNA splicing endonuclease subunit 54) This gene encodes a subunit of the tRNA splicing endonuclease complex, which catalyzes the removal of introns from precursor tRNAs. The complex is also implicated in pre-mRNA 3-prime end processing. Mutations in this gene result in pontocerebellar hypoplasia type 2.[provided by RefSeq, Oct 2009]
TSEN54 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 2A
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • pontocerebellar hypoplasia type 4
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
  • pontocerebellar hypoplasia type 5
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pontocerebellar hypoplasia type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.8462252E-6).
BP6
Variant 17-75523332-C-T is Benign according to our data. Variant chr17-75523332-C-T is described in ClinVar as [Benign]. Clinvar id is 160127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.693 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSEN54NM_207346.3 linkc.1310C>T p.Ala437Val missense_variant Exon 9 of 11 ENST00000333213.11 NP_997229.2 Q7Z6J9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSEN54ENST00000333213.11 linkc.1310C>T p.Ala437Val missense_variant Exon 9 of 11 1 NM_207346.3 ENSP00000327487.6 Q7Z6J9-1

Frequencies

GnomAD3 genomes
AF:
0.635
AC:
96395
AN:
151732
Hom.:
31158
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.580
Gnomad AMI
AF:
0.828
Gnomad AMR
AF:
0.508
Gnomad ASJ
AF:
0.606
Gnomad EAS
AF:
0.457
Gnomad SAS
AF:
0.648
Gnomad FIN
AF:
0.708
Gnomad MID
AF:
0.622
Gnomad NFE
AF:
0.698
Gnomad OTH
AF:
0.627
GnomAD2 exomes
AF:
0.617
AC:
155045
AN:
251440
AF XY:
0.632
show subpopulations
Gnomad AFR exome
AF:
0.582
Gnomad AMR exome
AF:
0.389
Gnomad ASJ exome
AF:
0.592
Gnomad EAS exome
AF:
0.439
Gnomad FIN exome
AF:
0.698
Gnomad NFE exome
AF:
0.692
Gnomad OTH exome
AF:
0.634
GnomAD4 exome
AF:
0.679
AC:
992514
AN:
1461720
Hom.:
341242
Cov.:
55
AF XY:
0.680
AC XY:
494720
AN XY:
727174
show subpopulations
African (AFR)
AF:
0.568
AC:
19023
AN:
33472
American (AMR)
AF:
0.404
AC:
18089
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.593
AC:
15503
AN:
26134
East Asian (EAS)
AF:
0.453
AC:
17987
AN:
39698
South Asian (SAS)
AF:
0.667
AC:
57517
AN:
86256
European-Finnish (FIN)
AF:
0.697
AC:
37212
AN:
53368
Middle Eastern (MID)
AF:
0.639
AC:
3687
AN:
5766
European-Non Finnish (NFE)
AF:
0.705
AC:
784003
AN:
1111916
Other (OTH)
AF:
0.654
AC:
39493
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
19317
38634
57950
77267
96584
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19652
39304
58956
78608
98260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.635
AC:
96426
AN:
151850
Hom.:
31161
Cov.:
31
AF XY:
0.633
AC XY:
46956
AN XY:
74190
show subpopulations
African (AFR)
AF:
0.579
AC:
23955
AN:
41362
American (AMR)
AF:
0.508
AC:
7749
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.606
AC:
2101
AN:
3466
East Asian (EAS)
AF:
0.456
AC:
2359
AN:
5168
South Asian (SAS)
AF:
0.647
AC:
3109
AN:
4802
European-Finnish (FIN)
AF:
0.708
AC:
7461
AN:
10544
Middle Eastern (MID)
AF:
0.631
AC:
183
AN:
290
European-Non Finnish (NFE)
AF:
0.698
AC:
47437
AN:
67950
Other (OTH)
AF:
0.626
AC:
1317
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1731
3462
5192
6923
8654
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
796
1592
2388
3184
3980
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.665
Hom.:
151276
Bravo
AF:
0.614
TwinsUK
AF:
0.709
AC:
2630
ALSPAC
AF:
0.714
AC:
2751
ESP6500AA
AF:
0.580
AC:
2557
ESP6500EA
AF:
0.702
AC:
6036
ExAC
AF:
0.624
AC:
75760
Asia WGS
AF:
0.563
AC:
1958
AN:
3478
EpiCase
AF:
0.682
EpiControl
AF:
0.681

ClinVar

Significance: Benign
Submissions summary: Benign:14
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontocerebellar hypoplasia type 2A Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontoneocerebellar hypoplasia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Pontocerebellar hypoplasia type 5 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontocerebellar hypoplasia type 4 Benign:1
Sep 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
16
DANN
Benign
0.82
DEOGEN2
Benign
0.022
T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.53
FATHMM_MKL
Benign
0.13
N
LIST_S2
Benign
0.73
T
MetaRNN
Benign
0.0000048
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
0.44
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.10
Sift
Benign
0.49
T
Sift4G
Benign
0.14
T
Polyphen
0.70
P
Vest4
0.027
MPC
0.26
ClinPred
0.013
T
GERP RS
0.51
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.018
gMVP
0.25
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8064529; hg19: chr17-73519413; COSMIC: COSV51350086; COSMIC: COSV51350086; API